Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
5AM Ventures is a San Francisco-based venture capital firm founded in 2002, dedicated to funding and building innovative life sciences companies. The firm has established itself as a leader in early-stage investments, particularly within the biopharmaceutical sector. With a current asset under management (AUM) of $450 million in its latest fund, 5AM Ventures has a strong track record of supporting the development of next-generation therapeutic technologies.
Over the years, 5AM Ventures has evolved its investment strategy to include a dual fund structure, allowing it to follow successful companies into later stages. This approach leverages insights from their public equity strategy, which targets small and mid-cap biotech firms. The firm operates from its headquarters in San Francisco and has an additional office in Boston, enhancing its reach within the life sciences sector.
5AM Ventures primarily invests in early-stage private therapeutic companies, with a strong emphasis on Series A financing. The firm focuses on sectors such as biotech, healthcare, medical devices, and pharma-tech. Their investment strategy is characterized by a hands-on approach, where they work closely with portfolio companies to enhance operational capabilities and accelerate growth. This operational support is complemented by their public equity strategy, which allows them to engage with small and mid-cap biotech and life science companies.
The firm is particularly interested in therapeutic technologies, including oncology, neuroscience, and rare diseases. 5AM Ventures seeks to build companies around platform technologies and corporate spinoffs, emphasizing a company creation model that fosters innovation in the life sciences.
5AM Ventures has a diverse portfolio of over 40 companies in the life sciences sector. Notable portfolio companies include:
Kush M Parmar, MD, PhD - Managing Partner, brings extensive experience in life sciences investing and has led numerous successful investments in the sector.
Andy J. Schwab - Managing Partner, has a strong background in venture capital and operational roles within biotech companies.
Anna Yaeger - Chief Investment Officer and Partner, specializes in investment strategy and portfolio management.
Michael Calore - Partner, Head of Investor Relations, focuses on building relationships with investors and stakeholders.
John Kelly - Partner, Chief Financial Officer & Chief Operating Officer, oversees financial operations and strategic planning.
Deborah Palestrant, PhD - Partner, Executive Chair, 4:59 Initiative, leads initiatives to incubate breakthrough science.
John D. Diekman, PhD - Founding Partner, has been instrumental in establishing the firm’s investment philosophy and strategy.
To pitch to 5AM Ventures, founders should visit their website at 5amventures.com. It is recommended to include a comprehensive pitch deck that outlines the technology, market opportunity, and team qualifications. Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
5AM Ventures operates the 4:59 Initiative, an internal program designed to discover, incubate, and fund breakthrough science. This initiative collaborates with academics and entrepreneurs to establish proof-of-concept data that can lead to Series A financing.
In recent activity, 5AM Ventures has secured significant funding for its portfolio companies, including Mendra's $82 million Series A and Kinaset Therapeutics' $103 million Series B. These investments highlight the firm's commitment to advancing innovative solutions in the life sciences sector.
Additionally, CAMP4 Therapeutics entered a strategic collaboration with GSK for RNA-based therapeutic discoveries, showcasing the firm's active role in fostering partnerships that enhance the potential of its portfolio companies.
Q?
What are the investment criteria for 5AM Ventures?
A 5AM Ventures primarily invests in early-stage private therapeutic companies, focusing on Series A financing in the life sciences sector, particularly in biotech and healthcare.
Q?
How can startups apply or pitch to 5AM Ventures?
A startups can pitch to 5AM Ventures through their website at 5amventures.com. It is advisable to include detailed information about the technology, market potential, and team in the pitch deck.
Q?
What makes 5AM Ventures different from other venture capital firms?
A 5AM Ventures employs a hands-on investment approach, providing operational support and strategic guidance to portfolio companies, which enhances their growth potential.
Q?
What is the geographic scope of 5AM Ventures?
A 5AM Ventures primarily invests in companies located in the United States, focusing on the life sciences sector.
Q?
What is the typical check size for investments made by 5AM Ventures?
A 5AM Ventures typically invests in the range of Series A financing, which can vary based on the specific needs of the portfolio company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.